The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...
Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...
Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...
Zacks.com on MSN17h
Incyte Gears Up to Report Q4 Earnings: Here's What You Should KnowIncyte Corporation INCY is scheduled to report fourth-quarter and full-year 2024 results on Feb. 10, before the opening bell.
CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback